PATENT CLAIM ANALYSIS

Application Number: 16011550
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["424", "186100"]

Abstract:
The present invention relates generally to immunization and immunotherapy for the treatment or prevention of HIV. In particular, the methods include in vivo and/or ex vivo enrichment of HIV-specific CD4+ T cells.

Claim (Index 13):
The method of  claim 9 , further comprising immunizing or having immunized the subject with an effective amount of an in vivo stimulatory agent, wherein the immunization occurs prior to contacting the peripheral blood mononuclear cells (PMBC) with the ex vivo stimulatory agent.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 94.0
- Lexical Diversity: 1.12903
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15668223', '13266236', '14254771', '15849062', '11683962']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7852664476604103
- 35 USC 102 Novelty (BERT): 0.6262223591561257
- Combined Prediction Score: 0.7693620388099819
- Mean Citation Score: 453.18526
- Max Citation Score: 770.7172
- Similarity Product: 514.9876868509053

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test